Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis

Journal Title: UNKNOWN - Year 2019, Vol 25, Issue 1

Abstract

.

Authors and Affiliations

Miraç Ayşen Ünsal

Keywords

Related Articles

Effect of Deep Brain Stimulation on Quality of Life in Patients with Parkinson’s Disease

Objective: To investigate the effect of deep brain stimulation (DBS) on quality of life (QOL) in patients with Parkinson’s disease (PD). Materials and Methods: The study included 19 patients with idiopathic PD who underw...

The Prevalence of Alternative-complementary Therapies in Patients with Multiple Sclerosis

Objective: Multiple sclerosis (MS) is a chronic demyelinating/degenerative disease of the central nervous system that causes disability in young adults. Complementary medicine (CM) and alternative medicine (AM) as a conc...

Evaluation of Inflammation with Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio in Restless Legs Syndrome

Objective: Restless legs syndrome (RLS) is a chronic, progressive sensorimotor disorder characterized by an irresistible urge to move the extremities-especially the legs-and abnormal sensations. Although symptoms are obs...

The Effect of Different ApoE Genotypes and Other Risk Factors on Obstructive Sleep Apnea Syndrome Formation

Objective: Obstructive sleep apnea syndrome (OSAS) is a disorder characterized by partial or complete narrowing of the pharyngeal airway during sleep. In this study it was aimed to investigate the relation between OSAS a...

Download PDF file
  • EP ID EP539573
  • DOI 10.4274/tnd.galenos.2019.00187
  • Views 97
  • Downloads 0

How To Cite

Miraç Ayşen Ünsal (2019). Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis. UNKNOWN, 25(1), 50-51. https://europub.co.uk./articles/-A-539573